Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Isoyama, 1998, Coronary vasculature in hypertrophy, 29
Krauser, 2006, Ventricular hypertrophy and hypertension: prognostic elements and implications for management, Herz, 31, 305, 10.1007/s00059-006-2819-5
Ghali, 1992, The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease, Ann Intern Med, 117, 831, 10.7326/0003-4819-117-10-831
Verdecchia, 2001, Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension, Circulation, 104, 2039, 10.1161/hc4201.097944
Verdecchia, 2006, Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects, Am J Hypertens, 19, 493, 10.1016/j.amjhyper.2005.10.018
Weber, 1991, Pathological hypertrophy and cardiac interstitium: fibrosis and renin–angiotensin–aldosterone system, Circulation, 83, 1849, 10.1161/01.CIR.83.6.1849
Verdecchia, 1996, Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy, Am J Cardiol, 78, 197, 10.1016/S0002-9149(96)00256-1
Krumholz, 1995, Prognosis of left ventricular geometric patterns in the Framingham Heart Study, J Am Coll Cardiol, 25, 879, 10.1016/0735-1097(94)00473-4
Ghali, 1998, Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease, J Am Coll Cardiol, 31, 1635, 10.1016/S0735-1097(98)00131-4
Milani, 2006, Left ventricular geometry and survival in patients with normal left ventricular ejection fraction, Am J Cardiol, 97, 959, 10.1016/j.amjcard.2005.10.030
Lavie, 2006, Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction, Am J Cardiol, 98, 1396, 10.1016/j.amjcard.2006.06.037
Koren, 1991, Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension, Ann Intern Med, 114, 345, 10.7326/0003-4819-114-5-345
Verdecchia, 1995, Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass, J Am Coll Cardiol, 25, 871, 10.1016/0735-1097(94)00424-O
Leoncini, 2006, Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension, Hypertension, 48, 397, 10.1161/01.HYP.0000236599.91051.1e
Khattar, 1999, Value of ambulatory intra-arterial blood pressure monitoring in the long-term prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension, J Hum Hypertens, 13, 111, 10.1038/sj.jhh.1000729
Watabe, 2006, Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study, Am J Hypertens, 19, 1199, 10.1016/j.amjhyper.2006.05.001
Verdecchia, 1999, Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension, Circulation, 100, 1802, 10.1161/01.CIR.100.17.1802
Rajala, 2002, Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery, J Clin Endocrinol Metab, 87, 5092, 10.1210/jc.2002-020703
Ito, 1993, Insulin-like growth factor-I induces cardiac hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes, Circulation, 87, 1715, 10.1161/01.CIR.87.5.1715
Sadoshima, 1993, Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac muscle in vitro, Cell, 75, 977, 10.1016/0092-8674(93)90541-W
Daugherty, 2000, Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice, J Clin Invest, 105, 1605, 10.1172/JCI7818
Crowley, 2006, Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney, Proc Natl Acad Sci U S A, 103, 17985, 10.1073/pnas.0605545103
Rettig, 2007, Angiotensin in the kidney: a key to understanding hypertension?, Cell Metab, 5, 7, 10.1016/j.cmet.2006.12.007
Lerman, 1991, Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis, N Engl J Med, 325, 997, 10.1056/NEJM199110033251404
Ichikawa, 1996, Endogenous endothelin-1 mediates cardiac hypertrophy and switching of myosin heavy chain gene expression in rat ventricular myocardium, J Am Coll Cardiol, 27, 1286, 10.1016/0735-1097(95)00568-4
Schillaci, 2001, High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension, J Hypertens, 19, 2265, 10.1097/00004872-200112000-00021
Avelar, 2007, Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass, Hypertension, 49, 34, 10.1161/01.HYP.0000251711.92482.14
Schulz, 2005, Changes in extracranial arteries in obstructive sleep apnoea, Eur Respir J, 25, 69, 10.1183/09031936.04.00030004
Davies, 2006, Evidence of a dominant backward-propagating ‘suction’ wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy, Circulation, 113, 1768, 10.1161/CIRCULATIONAHA.105.603050
Galderisi, 2003, Coronary flow reserve in hypertensive patients with appropriate and inappropriate left ventricular mass, J Hypertens, 21, 1, 10.1097/00004872-200311000-00029
McLenachan, 1987, Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy, N Engl J Med, 317, 787, 10.1056/NEJM198709243171302
Haider, 1998, Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death, J Am Coll Cardiol, 32, 1454, 10.1016/S0735-1097(98)00407-0
Rubulis, 2006, Ischemia induces aggravation of baseline repolarization abnormalities in left ventricular hypertrophy: a deleterious interaction, J Appl Physiol, 101, 102, 10.1152/japplphysiol.01334.2005
Rials, 1997, Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation, Circulation, 96, 1330, 10.1161/01.CIR.96.4.1330
Verdecchia, 2003, Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis, Am J Hypertens, 16, 895, 10.1016/S0895-7061(03)01018-5
Devereux, 2004, Prognostic significance of left ventricular mass change during treatment of hypertension, JAMA, 292, 2350, 10.1001/jama.292.19.2350
Okin, 2006, Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension, JAMA, 296, 1242, 10.1001/jama.296.10.1242